NEXGEL, Inc. (NXGL) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Instruments & Supplies 行业. 公司总部位于 Langhorne, PA, 美国. 现任CEO为 Adam R. Levy.
NXGL 拥有 IPO日期为 2021-12-22, 19 名全职员工, 在 NASDAQ Capital Marke, 市值为 $6.34M.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
